Company Update ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release BSE India Please find attached the final approval received from USFDA for Lamotrigine Extended Release Tablets USP 200 mg, 250 mg and 300 mg